FDA advisory committee conflict of interest
This article was originally published in The Tan Sheet
"Special government employees" granted conflict of interest waiver for product-specific advisory committee meetings must provide declaration prior to meeting disclosing nature, magnitude of the conflict, agency says in draft guidance released in January. Document provides guidelines on type, amount of information that must be disclosed to the public...
You may also be interested in...
FDA's draft guidance on the procedure for disclosing conflicts of interest will extend the agency's disclosure policy to cover all advisory committee members
FDA advisory committee members with large financial conflicts of interest should be recused from meetings in which these conflicts may come into play, Public Citizen recommends after conducting a study on voting patterns
FDA advisory committee members granted conflict of interest waivers should be required to disclose the companies to which they have financial ties, Bristol-Myers Squibb maintains in comments to FDA